FIELD: medicine, pharmaceutics.
SUBSTANCE: what is offered is a biologically active substance showing 5-HT3-serotonin receptor antagonist properties, 1-piperidinopropyl-2-(4-fluorophenyl)imidazo[1,2-a]benzimidazole of formula 
I. The compound has been known as a local anaesthetic. There are shown evident 5-HT3-antagonist properties of the compound in the macromolar concentration equal to the reference preparation ondansetron with the compound of formula I being safer.
EFFECT: new properties of the compound can be used for creating the effective agents exhibiting antiemetic, anxiolytic and analgesic activities.
2 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 9-(2-DIETHYLAMINOETHYL)-2-PHENYLIMIDAZO[1,2-a]BENZIMIDAZOLE HYDROBROMIDE ELICITING PROPERTY OF SEROTONIN 5-HT-RECEPTOR ANTAGONIST | 2005 |
|
RU2285006C1 |
| MEDICATIONS EXHIBITING PROPERTIES OF ANTAGONISTS OF SEROTONIN 5-HT- RECEPTORS | 2011 |
|
RU2465901C2 |
| KAPPA-OPIOID AGONIST | 2009 |
|
RU2413512C1 |
| ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
| 1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
| PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
| MEDICINAL SUBSTANCE FOR INHIBITION OF HELICOBACTER-LIKE EROSION-ULCEROUS INJURIES OF STOMACH MUCOSA | 2008 |
|
RU2395282C2 |
| ANTISPASMODIC MEDICATION | 2014 |
|
RU2568841C1 |
| SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS FOR APPLICATION IN TREATMENT OF LESIONAL VESTIBULAR DISORDERS | 2010 |
|
RU2608458C2 |
| AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
